CD40-mediated cell death requires TRAF6 recruitment

Immunobiology

Volumn 217, Issue 3, 2012, Pages 375-383

  Jundi, Malek ^a   Nadiri, Amal ^a   Al Zoobi, Loubna ^a   Hassan, Ghada S ^a   Mourad, Walid ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

CD40; Cell death; Lysosomes; Signaling; TRAFs

Indexed keywords

CASPASE; CATHEPSIN B; CD40 ANTIGEN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LYSOSOME MEMBRANE; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANTIGENS, CD40; APOPTOSIS; CELL DEATH; CELL LINE; CELL MEMBRANE PERMEABILITY; HUMANS; INTRACELLULAR MEMBRANES; LYSOSOMES; NF-KAPPA B; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 3; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84856434733     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2011.07.007     Document Type: Article

References (39)

1. Ahmed-Choudhury J., Russell C.L., Randhawa S., Young L.S., Adams D.H., Afford S.C. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation. Mol. Biol. Cell 2003, 14:1334-1345.
2. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 1997, 272:217-221.
3. Benoit N.E., Wade W.F. Increased inhibition of proliferation of human B cell lymphomas following ligation of CD40, and either CD19, CD20, CD95 or surface immunoglobulin. Immunopharmacology 1996, 35:129-139.
4. Bishop G.A., Hostager B.S. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003, 14:297-309.
5. Boya P., Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008, 27:6434-6451.
6. Craxton A., Shu G., Graves J.D., Saklatvala J., Krebs E.G., Clark E.A. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes. J. Immunol. 1998, 161:3225-3236.
7. Dugger K., Lowder T.W., Tucker T.A., Schwiebert L.M. Epithelial cells as immune effector cells: the role of CD40. Semin. Immunol. 2009, 21:289-292.
8. Eliopoulos A.G., Young L.S. The role of the CD40 pathway in the pathogenesis and treatment of cancer. Curr. Opin. Pharmacol. 2004, 4:360-367.
9. Elmetwali T., Young L.S., Palmer D.H. CD40 ligand-induced carcinoma cell death: a balance between activation of TNFR-associated factor (TRAF) 3-dependent death signals and suppression of TRAF6-dependent survival signals. J. Immunol. 2010, 184:1111-1120.
10. Fotin-Mleczek M., Henkler F., Hausser A., Glauner H., Samel D., Graness A., Scheurich P., Mauri D., Wajant H. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. J. Biol. Chem. 2004, 279:677-685.
11. Franklin R.A., McCubrey J.A. Kinases: positive and negative regulators of apoptosis. Leukemia 2000, 14:2019-2034.
12. Funakoshi S., Longo D.L., Beckwith M., Conley D.K., Tsarfaty G., Tsarfaty I., Armitage R.J., Fanslow W.C., Spriggs M.K., Murphy W.J. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 1994, 83:2787-2794.
13. Gauld S.B., Blair D., Moss C.A., Reid S.D., Harnett M.M. Differential roles for extracellularly regulated kinase-mitogen-activated protein kinase in B cell antigen receptor-induced apoptosis and CD40-mediated rescue of WEHI-231 immature B cells. J. Immunol. 2002, 168:3855-3864.
14. Georgopoulos N.T., Steele L.P., Thomson M.J., Selby P.J., Southgate J., Trejdosiewicz L.K. A novel mechanism of CD40-induced apoptosis of carcinoma cells involving TRAF3 and JNK/AP-1 activation. Cell Death Differ. 2006, 13:1789-1801.
15. Gerondakis S., Strasser A. The role of Rel/NF-kappaB transcription factors in B lymphocyte survival. Semin. Immunol. 2003, 15:159-166.
16. Girouard J., Reyes-Moreno C., Darveau A., Akoum A., Mourad W. Requirement of the extracellular cysteine at position six for CD40/CD40 dimer formation and CD40-induced IL-8 expression. Mol. Immunol. 2005, 42:773-780.
17. Gomes E.M., Rodrigues M.S., Phadke A.P., Butcher L.D., Starling C., Chen S., Chang D., Hernandez-Alcoceba R., Newman J.T., Stone M.J., Tong A.W. Antitumor activity of an oncolytic adenoviral-CD40 ligand (CD154) transgene construct in human breast cancer cells. Clin. Cancer Res. 2009, 15:1317-1325.
18. Hanissian S.H., Geha R.S. Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 1997, 6:379-387.
19. Hassan G.S., Rana M., Léveillé C., Nadiri A., Jundi M., Polyak M., El-Fakhry Y., Mourad W.M. Implication of CD154/CD40 interaction in healthy and autoimmune responses. Curr. Immunol. Rev. 2009, 5:285-299.
20. Hauer J., Puschner S., Ramakrishnan P., Simon U., Bongers M., Federle C., Engelmann H. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:2874-2879.
21. He L., Wu X., Siegel R., Lipsky P.E. TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB. J. Biol. Chem. 2006, 281:11235-11249.
22. Hess S., Engelmann H. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 1996, 183:159-167.
23. Hollmann C.A., Owens T., Nalbantoglu J., Hudson T.J., Sladek R. Constitutive activation of extracellular signal-regulated kinase predisposes diffuse large B-cell lymphoma cell lines to CD40-mediated cell death. Cancer Res. 2006, 66:3550-3557.
24. Honeychurch J., Glennie M.J., Johnson P.W., Illidge T.M. Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma. Blood 2003, 102:1449-1457.
25. Hostager B.S., Catlett I.M., Bishop G.A. Recruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 2000, 275:15392-15398.
26. Ivanov A., Beers S.A., Walshe C.A., Honeychurch J., Alduaij W., Cox K.L., Potter K.N., Murray S., Chan C.H., Klymenko T., Erenpreisa J., Glennie M.J., Illidge T.M., Cragg M.S. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J. Clin. Invest. 2009, 119:2143-2159.
27. Jaattela M. Programmed cell death: many ways for cells to die decently. Ann. Med. 2002, 34:480-488.
28. Jalukar S.V., Hostager B.S., Bishop G.A. Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 2000, 164:623-630.
29. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. 1997, 11:118-124.
30. Law C.L., Grewal I.S. Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv. Exp. Med. Biol. 2009, 647:8-36.
31. Lee J.R. Reactive oxygen species play roles on B cell surface receptor CD40-mediated proximal and distal signaling events: effects of an antioxidant, N-acetyl-l-cysteine treatment. Mol. Cell. Biochem. 2003, 252:1-7.
32. Lee J.R., Koretzky G.A. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur. J. Immunol. 1998, 28:4188-4197.
33. Leveille C., R.A.L.-D., Mourad W. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur. J. Immunol. 1999, 29:65-74.
34. Leveille C., Zekki H., Al-Daccak R., Mourad W. CD40- and HLA-DR-mediated cell death pathways share a lot of similarities but differ in their use of ADP-ribosyltransferase activities. Int. Immunol. 1999, 11:719-730.
35. Liu J., Yoshida Y., Yamashita U. Suppressive effect of reactive oxygen species on CD40-induced B cell activation. FEBS Lett. 2007, 581:5043-5049.
36. Reyes-Moreno C., Girouard J., Lapointe R., Darveau A., Mourad W. CD40/CD40 homodimers are required for CD40-induced phosphatidylinositol 3-kinase-dependent expression of B7.2 by human B lymphocytes. J. Biol. Chem. 2004, 279:7799-7806.
37. Reyes-Moreno C., Sharif-Askari E., Girouard J., Leveille C., Jundi M., Akoum A., Lapointe R., Darveau A., Mourad W. Requirement of oxidation-dependent CD40 homodimers for CD154/CD40 bidirectional signaling. J. Biol. Chem. 2007, 282:19473-19480.
38. Sundaresan M., Yu Z.X., Ferrans V.J., Irani K., Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 1995, 270:296-299.
39. Yellin M.J., Winikoff S., Fortune S.M., Baum D., Crow M.K., Lederman S., Chess L. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J. Leukoc. Biol. 1995, 58:209-216.